[HTML][HTML] Host-guest chemistry in supramolecular theranostics

G Yu, X Chen - Theranostics, 2019 - ncbi.nlm.nih.gov
Macrocyclic hosts, such as cyclodextrins, calixarenes, cucurbiturils, and pillararenes, exhibit
unparalleled advantages in disease diagnosis and therapy over the past years by fully …

[HTML][HTML] Blood–brain barrier modulation to improve glioma drug delivery

H Luo, EV Shusta - Pharmaceutics, 2020 - mdpi.com
The blood–brain barrier (BBB) is formed by brain microvascular endothelial cells that are
sealed by tight junctions, making it a significant obstacle for most brain therapeutics. The …

Inducible endothelial leakiness in nanotherapeutic applications

N Ni, W Wang, Y Sun, X Sun, DT Leong - Biomaterials, 2022 - Elsevier
All intravenous delivered nanomedicine needs to escape from the blood vessel to exert their
therapeutic efficacy at their designated site of action. Failure to do so increases the …

Microemulsion-based media in nose-to-brain drug delivery

A Froelich, T Osmałek, B Jadach, V Puri… - Pharmaceutics, 2021 - mdpi.com
Nose-to-brain drug delivery has recently attracted enormous attention as an alternative to
other delivery routes, including the most popular oral one. Due to the unique anatomical …

Features of the cytoprotective effect of selenium nanoparticles on primary cortical neurons and astrocytes during oxygen–glucose deprivation and reoxygenation

EA Turovsky, VN Mal'Tseva, RM Sarimov… - Scientific Reports, 2022 - nature.com
The study is aimed at elucidating the effect of selenium nanoparticles (SeNPs) on the death
of cells in the primary culture of mouse cerebral cortex during oxygen and glucose …

Glioma-derived exosomes hijack the blood–brain barrier to facilitate nanocapsule delivery via LCN2

C Yang, Y Wu, L Wang, S Li, J Zhou, Y Tan… - Journal of Controlled …, 2022 - Elsevier
Exosomes are small extracellular vehicles which could transport genetic materials and
proteins between cells. Although there are reports about exosomes crossing the blood-brain …

Recent development of contrast agents for magnetic resonance and multimodal imaging of glioblastoma

D Zhuang, H Zhang, G Hu, B Guo - Journal of Nanobiotechnology, 2022 - Springer
Glioblastoma (GBM) as the most common primary malignant brain tumor exhibits a high
incidence and degree of malignancy as well as poor prognosis. Due to the existence of …

NIR-II fluorescence visualization of ultrasound-induced blood–brain barrier opening for enhanced photothermal therapy against glioblastoma using indocyanine …

S Liang, D Hu, G Li, D Gao, F Li, H Zheng, M Pan… - Science bulletin, 2022 - Elsevier
Focused ultrasound (FUS)-induced blood–brain barrier (BBB) opening is crucial for
enhancing glioblastoma (GBM) therapies. However, an in vivo imaging approach with a high …

[HTML][HTML] Hypoxia-responsive lipid-poly-(hypoxic radiosensitized polyprodrug) nanoparticles for glioma chemo-and radiotherapy

L Hua, Z Wang, L Zhao, H Mao, G Wang, K Zhang… - Theranostics, 2018 - ncbi.nlm.nih.gov
Abstract Treatment of malignant glioma is a challenge facing cancer therapy. In addition to
surgery, and chemotherapy, radiotherapy (RT) is one of the most effective modalities of …

Ultrahigh-resolution visualization of vascular heterogeneity in brain tumors via magnetic nanoparticles-enhanced susceptibility-weighted imaging

Y Zhao, J Pan, B Han, W Hou, B Li, J Wang, G Wang… - ACS …, 2024 - ACS Publications
The precise assessment of vascular heterogeneity in brain tumors is vital for diagnosing,
grading, predicting progression, and guiding treatment decisions. However, currently, there …